Form 4 for SMTI Sanara MedTech Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-01 · accession 0001493152-22-000338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-04 | 2022-01-01 | SMTI | Fleming Zachary B. | CEO | A - Grant | $0.00 | +10.0K | 30.9K | +48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | A | A | 10,000 | $0.00 | 30,939 | D | — | — | (F1) Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on January 1, 2023, 2024 and 2025, respectively. |